COMMUNIQUÉS West-GlobeNewswire

IBA SA : IBA et Elekta signent un protocole d'entente portant sur le développement conjoint de software et de ventes pour soutenir le développement de la protonthérapie
23/09/2017
IBA et Elekta signent un protocole d'entente portant sur le développement conjoint de software et de ventes pour soutenir le développement de la protonthérapie SAN DIEGO, Etats-Unis, 23 septembre 2017 - IBA (Ion Beam [...]
IBA SA : IBA and Elekta enter an MOU regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments
23/09/2017
IBA and Elekta enter an MOU regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments SAN DIEGO, September 23, 2017 - IBA (Ion Beam Applications) and [...]
Abiomed obtient l'autorisation APMM de la FDA pour l'Impella RP® pour l'insuffisance cardiaque droite
22/09/2017
DANVERS, Massachusetts, le 22 septembre 2017 (GLOBE NEWSWIRE) - Abiomed, Inc. (NASDAQ : ABMD), fournisseur majeur de technologies innovantes d'assistance et de récupération cardiaque, a annoncé aujourd'hui qu'elle a [...]
Le portefeuille de propriété intellectuelle de Merus s'enrichit de deux nouveaux brevets grâce à sa technologie Biclonics®
22/09/2017
UTRECHT, Pays-Bas, le 20 septembre 2017 (GLOBE NEWSWIRE). -- Merus (NASDAQ : MRUS), société spécialisée en immuno-oncologie au stade clinique qui développe des traitements visant à guérir des maladies graves, a annoncé [...]
CEO Jyrki Eklund takes over the responsibilities of Aino Health Sweden AB
22/09/2017
Aino Health has progressed as planned in the internationalisation process. In the first part of this year, we have been able to develop both the Swedish and German markets. Structures are now in good shape in the [...]
Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus
22/09/2017
Trial now includes more than 730 patients under previously announced amended protocol Top-line results from TACTT3 expected in first quarter 2018 Zug, Switzerland, September 22, 2017 - Auris Medical Holding AG (NASDAQ: [...]
AroCell AB: TK 210 ELISA abstract on in-vitro studies of cancer drugs has been accepted for presentation at the National Cancer Research Institute (NCRI) UK symposium
22/09/2017
AroCell AB (publ) announces today that an abstract submitted Kiran Kumar Jagarlamudi et al entitled "The AroCell TK 210 ELISA provides new information concerning the mechanism of anti-cancer drugs by determining the TK1 [...]
Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
22/09/2017
Heidelberg, Germany, September 22, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. [...]
Zealand increases its share capital as a consequence of exercise of employee warrants
22/09/2017
Company announcement - No. 46 / 2017 Zealand increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 22, 2017 - Zealand has increased its share capital by a nominal amount of [...]
Solon Eiendom ASA : Primary insider notification
22/09/2017
(Oslo, Norway, 21 September 2017) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today acquired a forward contract with [...]
Participation de XBiotech à la conférence Global Healthcare de Cantor Fitzgerald
22/09/2017
AUSTIN, Texas, le 22 septembre 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui la participation de sa direction à la conférence Global Healthcare de Cantor Fitzgerald qui se tiendra du 25 au 27 [...]
Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs
22/09/2017
ORION CORPORATION PRESS RELEASE 22 SEPTEMBER 2017 at 8.30 EEST Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs Orion Pharma scientists [...]
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
22/09/2017
CMLPath to Care(TM) collaboration replaces Glivec International Patient Access Program (GIPAP) with a new, independent, patient-centered access model GIPAP was introduced 15 years ago and has provided approximately 75, [...]
Invitation to the extraordinary shareholders' meeting
22/09/2017
September 22, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan
22/09/2017
Regulated information Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB ® in Japan Asahi Kasei obtains exclusive license for the development and commercialisation of PREOB ® in Japan Option to [...]
Bone Therapeutics SA et Asahi Kasei signent un accord de licence exclusive portant sur PREOB® au Japon
22/09/2017
Information réglementée Bone Therapeutics et Asahi Kasei signent un accord de licence exclusive portant sur PREOB ® au Japon Licence exclusive délivrée à Asahi Kasei pour le développement et la commercialisation de [...]
Merus annonce ses résultats financiers du deuxième trimestre 2017 et souligne ses récents progrès
22/09/2017
UTRECHT, Pays-Bas, le 22 septembre 2017 (GLOBE NEWSWIRE). - Merus N.V. (NASDAQ : MRUS), entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics [...]
XBiotech annonce un accord avec le Cedars-Sinai Medical Center pour évaluer MABp1 en association avec Onivyde® et 5-fluorouracile / acide folinique pour le traitement du cancer du pancréas
22/09/2017
AUSTIN, Texas, le 22 septembre 2017 (GLOBE NEWSWIRE). - XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui son accord avec le Cedars-Sinai Medical Center situé à Los Angeles, en Californie, selon lequel XBiotech [...]
Galapagos increases share capital through warrant exercises
21/09/2017
Mechelen, Belgium; 21 September 2017, 22.00 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 28,100 new ordinary [...]

Pages